Feb 27, 2019 - IONS earnings call for the period ending December 31, 2018.
Feb 27, 2019 - Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2018 Earnings Conference Call February 27, 2019 11:30 AM ET Company Participants Wade Walke - Vice President, Investor Relations Stan Crooke - Chairman of
Feb 20, 2019 - Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Feb 20, 2019 - The regulatory go-ahead for the Ion platform is likely to provide Intuitive Surgical (ISRG) a competitive edge in the minimally-invasive-care space.
Feb 11, 2019 - Ion Geophysical's earnings report sent the stock price higher and the bond price lower.The company's cash generation was impaired by increased receivables, which should help its 2019 performance.The t
Feb 08, 2019 - ION Geophysical Corp. (NYSE:IO) Q4 2018 Earnings Conference Call February 07, 2019 10:00 AM ET Company Participants Rachel White - VP, Corporate Communications Brian Hanson - President, Director and C
Jan 28, 2019 - Is (IONS) Outperforming Other Medical Stocks This Year?
Jan 24, 2019 - Ironwood (IRWD) begins a phase I study on CNS-penetrant soluble guanylate cyclase stimulator, IW-6463, for treating severe CNS disorders.
Jan 16, 2019 - Defensive equities could ride out market unpredictability.
Jan 15, 2019 - FDA grants priority review to Pfizer's (PFE) regulatory filing looking for approval of pipeline candidate, tafamidis to treat transthyretin amyloid cardiomyopathy.